215 related articles for article (PubMed ID: 31257975)
1. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
[No Abstract] [Full Text] [Related]
2. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
3. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
Du YH; Ho PC
Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
6. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
Huang SG; Kong BH; Ma YY; Jiang S
Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Chung WH; Sung BH; Kim SS; Rhim H; Kuh HJ
Int J Oncol; 2009 Jun; 34(6):1669-79. PubMed ID: 19424586
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.
van Haaften C; Boot A; Corver WE; van Eendenburg JD; Trimbos BJ; van Wezel T
J Exp Clin Cancer Res; 2015 Apr; 34(1):38. PubMed ID: 25907439
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
Uslu R; Sanli UA; Sezgin C; Karabulut B; Terzioglu E; Omay SB; Goker E
Clin Cancer Res; 2000 Dec; 6(12):4957-64. PubMed ID: 11156257
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diarsenic oxide and tetraarsenic oxide on anticancer effects: relation to the apoptosis molecular pathway.
Chang HS; Bae SM; Kim YW; Kwak SY; Min HJ; Bae IJ; Lee YJ; Shin JC; Kim CK; Ahn WS
Int J Oncol; 2007 May; 30(5):1129-35. PubMed ID: 17390014
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
Shao QS; Ye ZY; Ling ZQ; Ke JJ
World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
[TBL] [Abstract][Full Text] [Related]
13. Arsenic Trioxide and Artemisinin Act Synergistically to Kill Tumor Cells
Zhao X; Yang S; Zhang D; Li Z; Huang C
Anticancer Agents Med Chem; 2018; 18(15):2178-2186. PubMed ID: 30179145
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
15. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
Ong PS; Chan SY; Ho PC
Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment with trabectedin and irinotecan or topotecan has synergistic effects against ovarian clear cell carcinoma cells.
Kawano M; Mabuchi S; Kishimoto T; Hisamatsu T; Matsumoto Y; Sasano T; Takahashi R; Sawada K; Takahashi K; Takahashi T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2014 Jun; 24(5):829-37. PubMed ID: 24844217
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
[TBL] [Abstract][Full Text] [Related]
19. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
[TBL] [Abstract][Full Text] [Related]
20. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
